{
    "organizations": [],
    "uuid": "e9842bc66ae44ac2aa0941d9389266281d07a10a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-xinguang-pharmaceutical-p/brief-zhejiang-xinguang-pharmaceutical-passes-review-of-high-tech-enterprise-recognition-idUSL4N1P41PX",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhejiang Xinguang Pharmaceutical passes review of high-tech enterprise recognition",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 9 (Reuters) - Zhejiang Xinguang Pharmaceutical Co Ltd :\n* Says it passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years since 2017\nSource text in Chinese: goo.gl/5TZ4Sg\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-09T11:25:00.000+02:00",
    "crawled": "2018-01-09T17:13:02.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "zhejiang",
        "xinguang",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "passed",
        "review",
        "enterprise",
        "recognition",
        "enjoy",
        "tax",
        "preference",
        "percent",
        "three",
        "year",
        "since",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}